OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Clinical Pharmacology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Issue Highlights	261
Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand	92
Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales	65
The impact of including a medication review in an integrated care pathway: A pilot study	62
Physiologically based pharmacokinetic modelling to predict potential drug–drug interactions of dersimelagon (MT‐7117)	57
Population pharmacokinetics of long‐term hydroxychloroquine therapy in patients with rheumatic diseases	55
Polygenic modelling and machine learning approaches in pharmacogenomics: Importance in downstream analysis of genome‐wide association study data	48
Selected Abstracts from Pharmacology 2024	48
Concentration‐QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study	47
Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing	46
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer	46
A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model	44
Acute cardiovascular effects associated with the use of prescription medications: A Danish nationwide screening study	44
The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis	44
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population	44
Investigating started sample size, completed sample size and drop‐out rate in 10 252 phase III clinical trials: Insights from ClinicalTrials.gov	43
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project	41
A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP	39
Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin	39
Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort	39
Drug–drug interaction study with itraconazole supplemented with physiologically based pharmacokinetic modelling to characterize the effect of CYP3A inhibitors on venglustat pharmacokinetics	38
Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator	37
Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination	36
Adverse events of alpelisib: A postmarketing study of the World Health Organization pharmacovigilance database	35
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database	34

Effects of itraconazole and carbamazepine on the pharmacokinetics of nirmatrelvir/ritonavir in healthy adults	32
	32
A 10‐year retrospective study of antibacterial‐induced thrombocytopenia in a women and children hospital using China Hospital Pharmacovigilance System and Visual Basic for Applications	31
Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies	31
Statistical inference in abstracts of 3 influential clinical pharmacology journals analysed using a text‐mining algorithm	31
	31
Associations between potentially inappropriate prescribing and increased number of medications with postdischarge health outcomes among geriatric rehabilitation inpatients: RESORT study	31